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IMPORTANCE Checklists have been shown to improve patient outcomes in surgery. The
intraoperatively used World Health Organization surgical safety checklist (WHO SSC) is now
mandatory in many countries. The only evidenced checklist to address preoperative and
postoperative care is the Surgical Patient Safety System (SURPASS), which has been found to
be effective in improving patient outcomes. To date, the WHO SSC and SURPASS have not
been studied jointly within the perioperative pathway.
OBJECTIVE To investigate the association of combined use of the preoperative and
postoperative SURPASS and the WHO SSC in perioperative care with morbidity, mortality, and
length of hospital stay.
DESIGN, SETTING, AND PARTICIPANTS In a stepped-wedge cluster nonrandomized clinical trial,
the preoperative and postoperative SURPASS checklists were implemented in 3 surgical
departments (neurosurgery, orthopedics, and gynecology) in a Norwegian tertiary hospital,
serving as their own controls. Three surgical units offered additional parallel controls. Data
were collected from November 1, 2012, to March 31, 2015, including surgical procedures
without any restrictions to patient age. Data were analyzed from September 25, 2018, to
March 29, 2019.
INTERVENTIONS Individualized preoperative and postoperative SURPASS checklists were
added to the intraoperative WHO SSC.
MAIN OUTCOMES AND MEASURES Primary outcomes were in-hospital complications,
emergency reoperations, unplanned 30-day readmissions, and 30-day mortality. The
secondary outcome was length of hospital stay (LOS).
RESULTS In total, 9009 procedures (5601 women [62.2%]; mean [SD] patient age, 51.7 [22.2]
years) were included, with 5117 intervention procedures (mean [SD] patient age, 51.8 [22.4]
years; 2913 women [56.9%]) compared with 3892 controls (mean [SD] patient age, 51.5
[21.8] years; 2688 women [69.1%]). Parallel control units included 9678 procedures (mean
[SD] patient age, 57.4 [22.2] years; 4124 women [42.6%]). In addition to the WHO SSC,
adjusted analyses showed that adherence to the preoperative SURPASS checklists was
associated with reduced complications (odds ratio [OR], 0.70; 95% CI, 0.50-0.98; P = .04)
and reoperations (OR, 0.42; 95% CI, 0.23-0.76; P = .004). Adherence to the postoperative
SURPASS checklists was associated with decreased readmissions (OR, 0.32; 95% CI,
0.16-0.64; P = .001). No changes were observed in mortality or LOS. In parallel control units,
complications increased (OR, 1.09; 95% CI, 1.01-1.17; P = .04), whereas reoperations,
readmissions, and mortality remained unchanged.
CONCLUSIONS AND RELEVANCE In this nonrandomized clinical trial, adding preoperative and
postoperative SURPASS to the WHO SSC was associated with a reduction in the rate of
complications, reoperations, and readmissions.
TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT01872195
JAMA Surg. doi:10.1001/jamasurg.2020.0989
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T he World Health Organization surgical safety checklist(WHO SSC), now used globally, has been found to re-duce complications and mortality,1-6 although nega-
tive findings have also been published.7,8 Questions have been
raised regarding whether negative results are due to a lack of
emphasis on the implementation and local tailoring.8-10 The
WHO SSC is used within the operating room, aiming to im-
prove teamwork, with shared awareness of the safety aspects
of surgery.11
However, surgical complications often originate before and
after operating room activities.12-14 The comprehensive Sur-
gical Patient Safety System (SURPASS) developed in the Neth-
erlands is the only surgical safety checklist to date to include
specific preoperative and postoperative checklists for indi-
vidual clinicians in addition to team checks in the operating
room. Like the WHO SSC, SURPASS has also been found to re-
duce complications and mortality.15 The effect of implement-
ing SURPASS has been replicated only in a smaller study from
India,16 which found that use of SURPASS alone reduced the
rate of postoperative complications in both elective and emer-
gency operations.
To date, whether surgical safety can improve further when
combining the intraoperative WHO SSC with the preopera-
tive and postoperative SURPASS remains unknown. This study
aimed to evaluate the associations of adding the preopera-
tive and postoperative SURPASS to the intraoperative WHO SSC
with surgical complications, all-cause 30-day mortality, and
subsequent length of hospital stay (LOS).
Methods
Study Design, Setting, and Oversight
The trial protocol is given in Supplement 1. A prospective,
stepped-wedge cluster nonrandomized clinical trial design17
was used. The study implemented the preoperative and post-
operative SURPASS checklists in 3 surgical departments in a
tertiary hospital in western Norway (Figure 1) in addition to
the WHO SSC. The study was approved by the regional ethi-
cal research committee, the data privacy units at the Health
Trust Førde, and Health Trust Fonna of Norway. After ap-
proval, the patients in the intervention departments received
written information on the study and their option to refrain
from data sharing. The study was exempt from written in-
formed consent. This study followed the extension of the 2010
Consolidated Standards of Reporting Trials (CONSORT) re-
porting guideline.18
At the time of the study (and to date), the WHO SSC is
mandatory in Norwegian operating rooms. The study design
allowed introduction of the SURPASS to each department
sequentially19 as opposed to a classic before-after design,
wherein the switch from before/control to after/intervention
is introduced for all the trial departments at the same time. The
original SURPASS15 and WHO SSC20 intervention trials are clas-
sic before-after studies. Our current design allows adjust-
ment for time trends and is advantageous in health care
settings with limited resources, involving continuous advance-
ments and change.19
Following advice from the WHO checklist implementa-
tion guideline, the trial departments were invited to partici-
pate based on their management commitment, frontline
positive engagement, and high adherence to the WHO SSC.21
The SURPASS intervention followed a stepwise introduction
in 1 department at a time. The departments each contributed
patient data before and after the study intervention and served
as their own controls, thus minimizing selection bias. Con-
tamination between study departments and the parallel
control departments—caused by information bias due to per-
sonnel working in several disciplines, sections, or depart-
ments—was avoided: The operating rooms and surgical teams
Key Points
Question Does patient safety improve when adding the
preoperative and postoperative Surgical Patient Safety System
checklists to the World Health Organization’s established surgical
safety checklist?
Findings In this stepped-wedge cluster nonrandomized clinical
trial with parallel controls that included 9009 surgical procedures,
reductions in complications and emergency reoperations occurred
when the preoperative Surgical Patient Safety System was added
to the surgical safety checklist. The postoperative Surgical Patient
Safety System reduced readmissions, whereas overall increased
complications were found in the 9678 parallel controls.
Meaning These findings suggest that joint use of the preoperative
and postoperative Surgical Patient Safety System with the
intraoperative surgical safety checklist is beneficial for patients.
Figure 1. Stepped-Wedge Cluster Nonrandomized Clinical Trial Design
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Implementation of the individualized preoperative and postoperative Surgical
Patient Safety System (SURPASS) checklists in 3 surgical clusters in a tertiary
hospital in Western Norway, November 2012 to March 2015 (29 months). A
indicates gynecology; B, orthopedics; and C, neurosurgery.
a Indicates pilot SURPASS intervention.
b Indicates 3-week pilot during June and July 2012.
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were geographically separate with their own organizational
units and specialized personnel (neurosurgery, orthopedic sur-
gery, and gynecology and the parallel control departments of
thoracic surgery, general surgery, vascular surgery, gastroen-
terology, urology, orthopedics, and ear, nose, and throat sur-
gery). Because single surgical procedures were subjects of
investigation, it was unlikely that any participant could have
been in both control and intervention groups, hence within-
department contamination was avoided. Three separate sur-
gical units in different hospitals (a tertiary hospital serving a
population of 1.1 million, a community hospital serving a popu-
lation of 110 000, and a community hospital serving a popu-
lation of 180 000) constituted additional parallel controls, with
the WHO SSC as standard care but without SURPASS.
Intervention
The original SURPASS system was developed to include known
risk factors described in the literature, validated against ac-
tual registered adverse events.14 The preoperative and post-
operative SURPASS checklists are individualized to be per-
formed by key clinicians in the surgical pathway. Each checklist
is to be used as a last point of check before transfer to the next
segment of the pathway, ensuring good planning and compli-
ance with existing perioperative care protocols at all transfer
points. Figure 2 displays the combined SURPASS and WHO SSC
checklists across the surgical pathway as implemented in this
study.
Before the trial, validation of the SURPASS checklist con-
tent into a Norwegian context was performed in a neurosur-
gical setting.22 Before checklist implementation in a new de-
partment, tailoring for specific conditions in the different
Norwegian departments was performed in accordance with ad-
vice in the WHO implementation manual.21 Implementation
of SURPASS was informed by our team’s extensive experi-
ence with implementing the WHO SSC in Norway23 and also
by recently compiled implementation strategies for health care
compendium developed by implementation scientists.24 In
brief, the implementation strategy included educational ses-
sions with frontline clinicians emphasizing why the check-
lists should be used, their evidence, and the practicalities of
how to apply them.25,26 Individual coaching was offered by the
research team. Moreover, an information campaign in the trial
departments was performed through distribution of printed
posters and emails to staff. Service managers and key clini-
cians in the different departments were designated champi-
ons of the SURPASS intervention. Last, audit and feedback on
SURPASS implementation fidelity (ie, quality of application)
was provided through regular compliance reports sent di-
rectly to all service managers by the research team.
Outcome Measures
Primary outcomes were in-hospital morbidity (complica-
tions, emergency reoperations, and 30-day readmissions) and
all-cause 30-day postoperative mortality. The secondary out-
come measure was LOS.
Inclusion and Exclusion Criteria
The study included in-hospital patients of all ages undergo-
ing an elective or an emergency surgical procedure. Excluded
were radiological interventions, donor surgery, extracorpo-
real membrane oxygenation procedures, outpatients, and
patients who declined to consent to the study.
Data Collection and Handling
Complications were investigated according to the Interna-
tional Statistical Classification of Diseases and Related Health
Problems, Tenth Revision (ICD-10) as routinely recorded by phy-
sicians. The method for validating the reported in-hospital
complications has been described previously.27 For the pres-
ent study, all 155 ICD-10 complication codes included in the
analyses were verified against each patient’s medical records
by the research team.
Data on mortality, LOS, patient characteristics, and surgi-
cal procedures were collected from the hospitals’ electronic
administrative systems and verified against each patient’s
medical record. Checklist data were combined with outcome
data after this verification procedure. Patient characteristics
included age, sex, American Society of Anesthesiologists (ASA)
physical health classification, urgency of surgery, type of sur-
gery, type of anesthesia, and time (month and year) of opera-
tion. Checklist adherence (ie, fidelity of application) was re-
corded per SURPASS checklist item and as the proportion of
individual checklists with all items checked. Thus, for the pre-
operative SURPASS, the proportions were 0, 0.20 for 1 check-
list, 0.40 for 2, 0.60 for 3, 0.80 for 4, and 1.00 for 5 (because
these have 5 parts in all). For the postoperative SURPASS and
WHO SSC, the proportions were 0, 0.33 for 1 checklist, 0.66
for 2, and 1.00 for 3 (because these have 3 parts in all). All
data were collected as part of daily routine patient documen-
tation, with staff blinded to outcome measures. All data










Preoperative SURPASS WHO SSC Postoperative SURPASS




1 indicates surgical pathway; 2, checkpoints for clinicians; and 3, Surgical Patient Safety System (SURPASS) or World Health Organization surgical safety checklist
(WHO SSC) applications. PACU indicates postanesthesia care unit.
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handlers were blinded to checklists used in the care of indi-
vidual patients.
Statistical Analysis
Data were analyzed from September 25, 2018, to March 29,
2019. Characteristics of the preoperative and postinter-
vention procedures and patient data were compared using the
Pearson exact test with Bonferroni corrections for categorical
variables and Gosset t tests for continuous variables. Intention-
to-treat analyses were performed to evaluate changes in com-
plication rates with comparison before and after the inter-
vention regardless of SURPASS compliance. Multiple logistic
regression analysis was used to evaluate associations of
SURPASS with patient outcomes and including actual adher-
ence to the checklists. Multiple Cox proportional hazards re-
gression was used to analyze LOS. The individual checklists
included in the analyses had all items checked. Preinterven-
tion and postintervention stages were analyzed while adjust-
ing for time associations and other possible confounders in the
logistic regression model,18,28 including age, sex, urgency of
operation, ASA classification, anesthesia given, surgical spe-
cialty, point of time for inclusion in the study, and WHO SSC
and SURPASS checklist adherence. Intention-to-treat analy-
ses were adjusted for the same variables, except SURPASS
adherence (as a proportion, as described above). With an ex-
pected mortality rate decrease from 0.015 to 0.008, a sample
size of 3641 patients undergoing surgery in both preinterven-
tion and postintervention groups was required to achieve a
power of 80% with an α value set to .05 (2 tailed). Intracluster
correlation was not considered to affect the study power ow-
ing to heterogeneity within and between departments. The re-
sults for complications and mortality are reported as odds
ratios (ORs) with 95% CIs and for LOS as hazard ratios (HRs).
Two-sided P ≤ .05 was set as statistically significant. Power
calculations were performed with SPPS Sample Power 2. Sta-
tistical analyses were performed using SPSS, version 24 (IBM
Corporation).
Results
The study included 3892 procedures at baseline and 5117 pro-
cedures in the intervention periods during the 29 months, from
November 1, 2012, to March 31, 2015 (Figure 1). A total of 7772
unique patients underwent 9009 procedures (mean [SD] pa-
tient age, 51.7 [22.2] years) in 8515 admissions within the study.
Characteristics of patients and surgical procedures are re-
ported in Table 1. The inclusion of gynecology as one of the study
departments contributed to an overall higher proportion of
women (5601 women [62.2%] and 3408 men [37.8%]; P < .001).
A total of 5117 intervention procedures (mean [SD] patient age,
51.8 [22.4] years; 2913 women [56.9%] and 2204 men [43.1%])
and 3892 controls (mean [SD] patient age, 51.5 [21.8] years; 2688
women [69.1%] and 1204 men [30.9%]) were included.
In total, 1418 of 9009 procedures (15.7%) were associated
with 1 or more complications (Table 2). In adjusted intention-
to-treat analyses, the number of complications decreased (OR,
0.73; 95% CI, 0.54-0.98; P = .04).
To analyze associations of complications per procedure
with preoperative and postoperative SURPASS added to the
WHO SSC, multiple logistic regression analyses were per-
formed accounting for the level of adherence. When adher-
ence to the preoperative SURPASS checklists was achieved, ad-
justed analysis demonstrated a decrease in in-hospital
complications (OR, 0.70; 95% CI, 0.50-0.98; P = .04) and emer-
gency reoperations (OR, 0.42; 95% CI, 0.23-0.76; P = .004)
(Table 3). Furthermore, adherence to the 3 postoperative SUR-
PASS checklists was associated with a reduction of un-
planned 30-day readmissions (OR, 0.32; 95% CI, 0.16-0.64;
P = .001) in adjusted analyses.
Analyzing time trends in adjusted Cox proportional
hazards regression showed an overall shorter LOS from early
to later in the study period (ie, an increasing chance of earlier
discharge; HR, 1.07 per year; 95% CI, 1.02-1.13; P = .003). Added
use of the SURPASS checklists showed no significant associa-
tions with LOS.
The 30-day in-hospital mortality associated with using the
preoperative SURPASS was nonsignificant (OR, 0.28; 95% CI,
0.04-1.78; P = .17). For postoperative SURPASS, the associa-
tion was likewise nonsignificant (OR, 0.86; 95% CI, 0.68-
1.08; P = .18). Similarly, there was no change in 30-day
mortality after discharge associated with use of either the pre-
operative SURPASS (OR, 1.67; 95% CI, 0.38-7.44; P = .50) or the
postoperative SURPASS (OR, 0.64; 95% CI, 0.17-2.45; P = .51)
in all adjusted analyses.
The 3 parallel control surgical units included 9678 proce-
dures during the study period (mean [SD] patient age, 57.4
[22.2] years; 4124 women [42.6%] and 5554 men [57.4%]). A
CONSORT flow diagram describing eligible procedures is rep-
resented in the eFigure in Supplement 2. Characteristics of the
procedures and outcome measures are reported in eTables 1
and 2 in Supplement 2, respectively. There was an overall de-
crease in LOS in the control units during the study period, with
an increased chance of being more rapidly discharged (HR, 1.07
per year; 95% CI, 1.04-1.11; P < .001). We also found an in-
crease in complications over time (OR, 1.09; 95% CI, 1.01-1.17;
P = .04) (eTable 3 in Supplement 2). In adjusted analyses, no
changes were observed in emergency reoperations (OR, 0.96;
95% CI, 0.82-1.12; P = .57), 30-day readmissions (OR, 1.17;
95% CI, 0.96-1.42; P = .11), 30-day in-hospital mortality
(OR, 0.95; 95% CI, 0.70-1.29; P = .73), or 30-day mortality
after discharge (OR, 1.14; 95% CI, 0.81-1.59; P = .46) in these
departments.
Discussion
Findings from this study demonstrate that adding the preop-
erative and postoperative SURPASS checklists to the intraop-
erative WHO SSC may be clinically advantageous. We found
that the joint application of the 2 surgical checklist systems was
associated with reduced in-hospital complications, emer-
gency reoperations, and hospital readmissions.
A decade ago, the WHO SSC was initially implemented in
2 Norwegian hospitals (one being the present trial hospital),
resulting in a 42% relative risk reduction of complications from
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19.9% to 12.4%.23 Although the WHO SSC has become na-
tional clinical policy for surgery, evidence shows that surgi-
cal complications often originate outside the operating
room.12-14 Logically, this outcome suggests that a checklist to
improve flow of information and completeness of requisite
clinical care protocols before a patient reaches the operating
room can reduce unwanted variation in preparation and plan-
ning and improve care.29 Our findings suggest that effective
application of the preoperative SURPASS may achieve this. The
reduction in emergency reoperations when preoperative SUR-
PASS had been used replicates studies showing a decrease in
reoperations after implementing intraoperative surgical
checklists.20,30,31
Furthermore, better use of the 3 postoperative SURPASS
checklists was associated with decreased readmissions to hos-
pital within 30 days. Improved communications optimize care
delivery in transfer of patients to other units.12,32-35 The clini-
cal associations we observed could be owing to the SURPASS
discharge checklists supporting better preparation of pa-
tients when leaving the hospital (ie, plans for their medica-
tions and expectations regarding their ongoing recovery). Other
studies have found that patient discharge is strengthened by
use of checklists,36 and decreased readmissions have been
linked to use of the WHO SSC.37
The parallel control units had increased complication rates
over time, whereas rates of emergency reoperations, 30-day
readmissions, and mortality remained unchanged. Over time,
we observed an overall increased complication rate in both trial
and control units. We do not have data directly addressing this
finding. We hypothesize, however, that the national context
of the study may account for this pattern. National economic
incentive systems reimbursing ICD-10 codes for complicated
Table 1. Characteristics of 9009 Surgical Procedures in a Stepped-Wedge Cluster Nonrandomized Clinical Trial
Characteristic
Study groupa
P valuedControl (n = 3892)b Intervention (n = 5117)c
Male sex 1204 (30.9) 2204 (43.1) <.001
Age, mean (SD), y 51.5 (21.8) 51.8 (22.4) .49
ASA risk scoree
I 1020 (26.2) 1385 (27.1)
.14
II 2115 (54.4) 2630 (51.4)
III 706 (18.2) 998 (19.5)
IV 44 (1.1) 100 (2.0)
V 1 (0.02) 3 (0.1)
Surgery
Elective 1878 (48.3) 2270 (44.4)
<.001
Emergency 2014 (51.7) 2847 (55.6)
Anesthesia
Regional 1310 (33.7) 1794 (35.1)
.172
General 2582 (66.3) 3323 (64.9)
Surgical specialty
Neurosurgery 636 (16.3) 1903 (37.2)
<.001Orthopedics 1827 (46.9) 2612 (51.0)
Gynecology 1429 (36.7) 602 (11.8)
SURPASS preoperative checklists, No.f
0 NA 216 (4.2)
NA
1 NA 503 (9.8)
2 NA 1034 (20.2)
3 NA 1903 (37.2)
4 NA 1176 (23.0)
5 NA 285 (5.6)
WHO SSC intraoperative checklists, No.f
0 48 (1.2) 39 (0.8)
<.001
1 192 (4.9) 251 (4.9)
2 808 (20.8) 1442 (28.2)
3 2844 (73.1) 3385 (66.2)
SURPASS postoperative checklists, No.f
0 NA 1397 (27.3)
NA
1 NA 2789 (54.5)
2 NA 595 (11.6)
3 NA 336 (6.6)
Abbreviations: ASA, American
Society of Anesthesiologists’ risk
score; NA, not applicable; SURPASS,
Surgical Patient Safety System;
WHO SSC, World Health Organization
surgical safety checklist.
a Unless otherwise indicated, data are
expressed as number (percentage)
of procedures. Percentages have
been rounded and may not total
100. Data are from 1 hospital in
Western Norway from November
2012 through March 2015.
b Includes 3274 unique patients.
c Includes 4498 unique patients.
d Calculated from Pearson exact test
with Bonferroni corrections except
ASA risk score (not exact test) and
age (Gosset t test).
e Missing for 6 control group
procedures and 1 intervention group
procedure. Higher scores indicate
more comorbidities.
f All items of individual checklists
checked.
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admissions have increased hospitals’ focus on coding
practices.38 A possible explanation may be increased hospital
focus on more accurate coding practice for reimbursement pur-
poses by individual physicians throughout the study period.
The increase in complications is unlikely to reflect a lack of ef-
fect from the checklist intervention, because when adjusted
regression analyses were performed, the intervention was
associated with lower risk of complications. Also, stricter ad-
herence to the SURPASS checklists had a lower risk of compli-
cations than looser adherence, indicating a dose-response ef-
fect. Furthermore, use of the stepped-wedge design allowed
us to adjust for time trends in complication rates.17 Both the
trial departments and the control units had an overall de-
crease in LOS over time, and LOS was not associated with use
of the SURPASS in the intervention departments. This find-
ing contrasts with those of previous studies, which showed re-
duction in LOS with checklist use.23,39 We consider it pos-
sible that maximum reduction of LOS had been reached in our
study owing to the national Norwegian context. Specifically,
a national coordination reform took effect in January 2012.40
One of the main goals of the reform was to reduce LOS in hos-
pitals by a build-up and enhancement of publicly funded nurs-
ing homes. This national policy program likely affected
discharge decision-making throughout the study period and
thus affected our findings. Our findings cannot directly sup-
port this explanation, which can be evaluated further through
longitudinal outcome studies.
Strengths and Limitations
This study has several strengths, including the prestudy
SURPASS validation process, study design, long-term collec-
tion of data, and strong engagement from hospital leaders,
managers, and influential clinicians when implementing the
SURPASS intervention, thus achieving good fidelity. In addi-
tion, the validation procedures with exact and extensive
verification of in-hospital ICD-10 codes for complications,
Table 2. Characteristics of Outcomes Before and After Intervention With SURPASS Checklists
Added to WHO SSC
Outcome
Study groupa
P valuebControl (n = 3892) Intervention (n = 5117)
Respiratory 41 (1.1) 76 (1.5) .08
Pneumonia 34 (0.9) 69 (1.3) .045
Respiratory other 10 (0.3) 13 (0.3) >.99
Cardiac 31 (0.8) 27 (0.5) .14
Cardiac arrhythmia 7 (0.2) 14 (0.3) .39
Congestive heart failure 14 (0.4) 9 (0.2) .10
Cardiac other 13 (0.3) 7 (0.1) .07
Infections 89 (2.3) 161 (3.1) .01
Sepsis 7 (0.2) 10 (0.2) >.99
Surgical site 13 (0.3) 7 (0.1) .07
Urinary tract 68 (1.7) 138 (2.7) .003
Infections other 4 (0.1) 11 (0.2) .30
Surgical wound rupture 7 (0.2) 4 (0.1) .23
Nervous system 11 (0.3) 18 (0.4) .58
Delirium 6 (0.2) 12 (0.2) .48
Cerebral infarction 5 (0.1) 7 (0.1) >.99
Bleeding 105 (2.7) 201 (3.9) .001
Embolism 12 (0.3) 8 (0.2) .17
Nutrition 21 (0.5) 85 (1.7) <.001
Malnutrition 7 (0.2) 56 (1.1) <.001
Other disorders 14 (0.4) 44 (0.9) .003
Anesthesia 6 (0.2) 4 (0.1) .35
Mechanical implantation 4 (0.1) 3 (0.1) .71
Fall 0 5 (0.1) .07
Other 65 (1.7) 73 (1.4) .39
Emergency reoperations 153 (3.9) 218 (4.3) .45
Readmissionsc 128 (3.5) 149 (3.1) .32
Overall complicationsd 574 (14.7) 844 (16.5) .03
Length of stay, dc
Mean (SD) 5.8 (17.7) 5.6 (5.7)
.43
Median (IQR) 4.0 (2.0-7.0) 4.1 (2.2-6.9)
Mortality within 30 d in-hospitale,f 23 (0.7) 28 (0.6) .67
Mortality after dischargef 24 (0.7) 32 (0.7) >.99
Abbreviations: IQR, interquartile
range; SURPASS, Surgical Patient
Safety System; WHO SSC, World
Health Organization surgical safety
checklist.
a Unless otherwise indicated, data are
expressed as number (percentage)
of procedures.
b Calculated using the 2-sided
Pearson exact test with Bonferroni
corrections for binary variables and
Gosset t test for length of hospital
stay.
c Includes 3680 admissions in the
control group and 4835 in the
intervention group.
d Included in overall complications are
155 International Statistical
Classification of Diseases and
Related Health Problems, Tenth
Revision complication codes verified
from unique surgical procedures,
and emergency reoperations and
30-day readmissions.
e Indicates 30 days or less from first
operation on last hospital
admission.
f Includes 3274 patients in the
control group and 4498 in the
intervention group.
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emergency reoperations, readmissions, mortality, and LOS
from patient records linked to actual checklist adherence al-
lowed reliable outcome measurement.27 Furthermore, the
study allows distinguishing which checklists are associated
with improvements on which outcomes. For example, com-
bined use of the preoperative and postanesthesia care unit
nurses’ SURPASS with the WHO SSC may improve in-hospital
complications, in-hospital mortality, and LOS. Use of preop-
erative SURPASS checklists and the WHO SSC may influence
emergency reoperations. A combined use of preoperative and
postoperative SURPASS and WHO SSC may influence un-
planned hospital readmissions and mortality after discharge.
The study also has limitations. The nonsignificant change
in mortality could be owing to an underpowered sample size.
The calculation was performed in 2012 based on the published
literature.15,20 However, the number of patients dying in our
sample was lower than anticipated. Furthermore, an impor-
tant consideration is whether there could be any residual con-
founders explaining the observed higher rate of complications
after the intervention. For example, were more complex pro-
cedures performed in sicker patients after the intervention? In
Table 1, we showed that there is no difference in comorbidity
(ASA classification) between control and intervention depart-
ments. In the regression analyses, we have adjusted for case
mixes, including age, sex, emergency procedures, ASA classi-
fication, anesthesia given, surgical specialty, point of time for
inclusion in the study, and checklist use. Additional comorbid-
ity measures such as the Charlson comorbidity index were
not part of the original study protocol. However, with these rig-
orous adjusted analyses, we believe that very little residual
confounding has remained unexplained.
The parallel control units contributed different surgical pro-
cedures and specialties to the trial compared with the inter-
vention departments. Comparing outcome data on similar pro-
cedures and specialties would have been ideal. However,
morbidity and mortality trends in the parallel controls were
similar to those of the intervention departments. The actual
complexity of the SURPASS intervention, involving different
professional groups across different departments, added an
inherent limitation, because randomizing the start-up of the
intervention with the time and resources available became
unfeasible.
In addition, overall high-fidelity application of all check-
lists across all professional groups for all surgical procedures was
not obtained. Known implementation barriers affect checklist
use globally (eg, information technology systems, checklist and
personnel flow, checklist resistance, and/or checklist fatigue) and
could have resulted in underestimations of the sizes of associa-
tions of intervention and clinical outcomes in our analyses. Other
investigators41 have also raised these issues. Further studies of
how to improve fidelity in delivering clinically effective check-
lists in surgical pathways are warranted.
Conclusions
Our findings suggest that combinations of the WHO and
SURPASS checklists throughout the perioperative pathway may
be clinically advantageous in improving processes of care and
patient safety further with reductions in complications, reop-
erations, and readmissions beyond what sole use of the WHO
checklist in the operating room achieves. The WHO checklist
has been adopted globally for use in operating rooms. The next
step to increase surgical patient safety is to use safety check-
lists throughout the perioperative pathway, as when combin-
ing the WHO checklist with SURPASS checklists. Rigorous large-
scale multicenter randomized clinical trials are recommended
to investigate this further.
Table 3. Results From Logistic Regression of the Effects of Preoperative and Postoperative SURPASS
Checklists Plus WHO SSC on 1 or More Complications in 9002 Surgical Proceduresa
Variables
Unadjusted model Fully adjusted model
OR (95% CI) P value OR (95% CI) P value
SURPASS preoperative 0.97 (0.82-1.15) .74 0.70 (0.50-0.98) .04
SURPASS postoperative 1.02 (0.99-1.05) .20 1.01 (0.97-1.05) .65
WHO SSC 0.72 (0.55-0.94) .02 0.90 (0.68-1.19) .46
Male sex 0.92 (0.82-1.04) .18 0.97 (0.85-1.11) .67
Age, per 10 y 1.24 (1.20-1.27) <.001 1.11 (1.08-1.15) <.001
Month of operationb 1.14 (1.06-1.22) <.001 1.23 (1.08-1.40) .002

















.02Orthopedics 1.12 (0.98-1.28) 0.82 (0.69-0.96)
Gynecology 0.89 (0.75-1.05) 1.03 (0.84-1.28)
Abbreviations: ASA, American
Society of Anesthesiologists;
OR, odds ratio, effect size;
SURPASS, Surgical Patient Safety
System; WHO SSC, World Health
Organization surgical safety checklist.
a Calculated as proportions of
checklists used. SURPASS included 5
preoperative checklists and 1
postoperative postanesthesia care
unit nurse checklist;
WHO SCC, 3 checklists.
Preoperative SURPASS includes 0
for no checklist and 1 to 5
checklists (proportions, 0.20, 0.40,
0.60, 0.80, and 1.00);
postoperative SURPASS and WHO
SSC, 0 for no checklist and 1 to 3
checklists (proportions, 0.33, 0.66,
and 1.00).
b Time for inclusion in the study, per
year.
c Scores range from I to V, with higher
scores indicating greater
comorbidities.
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